Scarica l'app Stockscreener
221.45
0.81%
1.77
Pre-mercato:
221.44
-0.010
-0.00%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABBV Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$219.68
Aprire:
$221.09
Volume 24 ore:
3.99M
Relative Volume:
0.60
Capitalizzazione di mercato:
$391.56B
Reddito:
$61.16B
Utile/perdita netta:
$4.19B
Rapporto P/E:
93.78
EPS:
2.3614
Flusso di cassa netto:
$17.82B
1 W Prestazione:
-2.64%
1M Prestazione:
-4.34%
6M Prestazione:
+2.40%
1 anno Prestazione:
+4.57%
Intervallo 1D:
$220.31
$224.37
Intervallo di 1 settimana:
$219.44
$231.26
Portata 52W:
$164.39
$244.81
Abbvie Inc Stock (ABBV) Company Profile
Nome
Abbvie Inc
Settore
Industria
Telefono
(847) 932-7900
Indirizzo
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Compare ABBV vs LLY, JNJ, AZN, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
221.45 | 391.56B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
LLY
Lilly Eli Co
|
989.12 | 883.28B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
243.19 | 586.06B | 94.19B | 26.80B | 19.70B | 11.05 |
|
AZN
Astrazeneca Plc
|
192.01 | 297.77B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
154.87 | 295.52B | 54.72B | 14.02B | 15.32B | 7.1855 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-02-20 | Iniziato | Barclays | Overweight |
| 2026-01-08 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2026-01-07 | Ripresa | UBS | Neutral |
| 2025-12-10 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-11-04 | Downgrade | DZ Bank | Buy → Hold |
| 2025-10-14 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-01 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-09-17 | Aggiornamento | Berenberg | Hold → Buy |
| 2025-08-12 | Ripresa | Piper Sandler | Overweight |
| 2025-08-07 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-10 | Ripresa | BofA Securities | Neutral |
| 2024-12-05 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-11-04 | Aggiornamento | Argus | Hold → Buy |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-06-05 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-05-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-01-29 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | Downgrade | HSBC Securities | Buy → Hold |
| 2023-12-11 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-10-30 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Ripresa | UBS | Neutral |
| 2023-09-29 | Iniziato | Raymond James | Outperform |
| 2023-07-25 | Iniziato | William Blair | Mkt Perform |
| 2023-07-14 | Iniziato | HSBC Securities | Buy |
| 2023-04-05 | Downgrade | Argus | Buy → Hold |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2023-02-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | Aggiornamento | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-11-08 | Downgrade | Societe Generale | Buy → Hold |
| 2022-08-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | Iniziato | SVB Leerink | Underperform |
| 2022-05-06 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2022-02-28 | Downgrade | UBS | Buy → Neutral |
| 2022-02-03 | Reiterato | BMO Capital Markets | Outperform |
| 2022-02-03 | Reiterato | Barclays | Equal Weight |
| 2022-02-03 | Reiterato | BofA Securities | Neutral |
| 2022-02-03 | Reiterato | Goldman | Neutral |
| 2022-01-13 | Iniziato | Redburn | Buy |
| 2022-01-12 | Reiterato | BMO Capital Markets | Outperform |
| 2021-12-09 | Ripresa | Wells Fargo | Overweight |
| 2021-11-23 | Aggiornamento | Societe Generale | Hold → Buy |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-06-23 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Aggiornamento | Argus | Hold → Buy |
| 2020-05-18 | Ripresa | BofA/Merrill | Neutral |
| 2020-05-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-05-11 | Ripresa | Morgan Stanley | Overweight |
| 2020-04-20 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | Downgrade | Societe Generale | Buy → Hold |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-02-06 | Iniziato | Mizuho | Buy |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | Reiterato | Cowen | Outperform |
| 2019-09-26 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-08-20 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-04-29 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
Mostra tutto
Abbvie Inc Borsa (ABBV) Ultime notizie
Bamco Inc. NY Invests $4.86 Million in AbbVie Inc. $ABBV - MarketBeat
This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally - The Motley Fool
William Blair Asserts AbbVie Inc. (ABBV) Growth Prospects on Obesity Treatment Opportunities - Yahoo Finance
AbbVie (ABBV) Unveils Skin Quality Index Following Comprehensive Study - GuruFocus
AbbVie’s Allergan Aesthetics launches Skin Quality Index - TipRanks
Iron Triangle Partners LP Has $46.38 Million Position in AbbVie Inc. $ABBV - MarketBeat
Allergan Aesthetics Redefines Skin Quality Communication with Launch of Skin Quality Index - AbbVie News Center
Hamilton Wealth LLC Makes New $4.92 Million Investment in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Focus Partners Wealth - MarketBeat
Fred Alger Management LLC Acquires 54,335 Shares of AbbVie Inc. $ABBV - MarketBeat
Elevation Point Wealth Partners LLC Buys 8,652 Shares of AbbVie Inc. $ABBV - MarketBeat
Brevan Howard Capital Management LP Sells 26,408 Shares of AbbVie Inc. $ABBV - MarketBeat
Assessing AbbVie (ABBV) Valuation After Recent Share Price Weakness - simplywall.st
Is AbbVie Inc. (ABBV) a good stock to buy now? - MSN
Is AbbVie Inc. (ABBV) A Good Stock to Buy Now? - Insider Monkey
AbbVie Inc. $ABBV is Crawford Investment Counsel Inc.'s 2nd Largest Position - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Capitolis Liquid Global Markets LLC - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Calydon Capital - MarketBeat
Cannell & Spears LLC Decreases Stake in AbbVie Inc. $ABBV - MarketBeat
Chevy Chase Trust Holdings LLC Trims Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Cinctive Capital Management LP - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Reduces AbbVie Inc. Stake - National Today
California Public Employees Retirement System Raises Holdings in AbbVie Inc. $ABBV - MarketBeat
Clark Capital Management Group Inc. Acquires 90,508 Shares of AbbVie Inc. $ABBV - MarketBeat
Bridgefront Capital LLC Sells 6,779 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. Stock (ISIN: US00287Y1091) Faces Analyst Downgrade Amid High Valuation Concerns - AD HOC NEWS
Ameriprise Financial Inc. Acquires 408,426 Shares of AbbVie Inc. $ABBV - MarketBeat
Is AbbVie Inc. (ABBV) one of the debt free halal stocks to buy? - MSN
Bimzelx Trial Win Raises New Questions For AbbVie Skyrizi Outlook - simplywall.st
von Borstel & Associates Inc. Takes Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Zuckerman Investment Group LLC - MarketBeat
AbbVie Inc. $ABBV Stock Position Decreased by Prudential PLC - MarketBeat
NorthRock Partners LLC Has $19.23 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Temasek Holdings Private Ltd Purchases 25,496 Shares of AbbVie Inc. $ABBV - MarketBeat
Regal Investment Advisors LLC Cuts Position in AbbVie Inc. $ABBV - MarketBeat
ABBV Stock Quote Price and Forecast - CNN
AbbVie Inc. $ABBV Shares Sold by Diligent Investors LLC - MarketBeat
Harvest Fund Management Co. Ltd Acquires 10,588 Shares of AbbVie Inc. $ABBV - MarketBeat
Comerica Bank Has $181.67 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Glenmede Investment Management LP Has $78.78 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie (ABBV) Receives a Buy from Berenberg Bank - The Globe and Mail
AbbVie (ABBV) Dips More Than Broader Market: What You Should Know - Yahoo Finance
AbbVie (NYSE:ABBV) Shares Down 2.5%Here's Why - MarketBeat
AbbVie Inc. stock underperforms Friday when compared to competitors - MarketWatch
Is AbbVie Inc. (ABBV) One of the Debt Free Halal Stocks to Buy? - Insider Monkey
Tocqueville Asset Management L.P. Cuts Stock Position in AbbVie Inc. $ABBV - MarketBeat
Kennedy Capital Management LLC Sells 24,196 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc Stock (ISIN: US00287Y1091) Faces Pressure Amid Valuation Concerns and Dividend Appeal - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Pliant Therapeutics (PLRX) and Opus Genetics (IRD) - The Globe and Mail
Martingale Asset Management L P Sells 14,724 Shares of AbbVie Inc. $ABBV - MarketBeat
Invesco Ltd. Raises Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Abbvie Inc Azioni (ABBV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):